World Journal of Pharmaceutical
Science and Research

A Global Platform for Open Access, Peer-Reviewed, and Indexed Research in the
Pharmaceutical and Medical Sciences


Login | Registration


ISSN: 2583-6579


Impact Factor: 6.916

ABSTRACT

RATIONAL DESIGN OF PYRIMIDINE DERIVATIVES AS ANTICANCER AGENT

Anju Palanaden*, Afeefa N., Swathi S., Hana Asees T. C., Mohammed Anzal Rahamathulla

Pyrimidine is a six membered aromatic heterocyclic compound containing two nitrogen atom at position 1 & 3. Pyrimidine derivative has been used in drugs for various diseases. in this ,we use insilico drug design techniques to determine pharmacokinetics properties and binding affinity of 2 amino[1,3] thiazolo [4,5-d] pyrimidine5,7 [4h,6h]-dione and 4,6dimethy l-2 phenyl [1,3] oxozolo [4,5-d] pyrimidine-5,6 [4h,6h]-dione. The molecular structure were drawn using chemsketch, followed by prediction of pharmacokinetics properties by swiss ADME. The binding affinity was by using the docking software PyRx. Among this the compound 4, 6-dimethyl 2-phenyl [1,3] oxazolo [4,5-d] pyrimidine -5,7 [4h,6h]-dione has better anti-cancer activity based on binding affinity.

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our 2026 IMPACT FACTOR has increased from 5.111 to 6.916

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    June 2026 Issue Now Available

    June 2026 Issue is now available online for readers and contributors. Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Upcoming Issue (2026)

    The journal invites researchers, academicians, and scholars to submit their original research articles, review papers, and case studies for the upcoming July 2026 Issue . All submissions will undergo a standard peer-review process.